COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1529: Articles 15281-15290  | Next

SARS-CoV-2 Variant of Concern Substitutions Alter Spike Glycoprotein Receptor Binding Domain Structure and Stability
Moss, D. L., Rappaport, J.
10.1101/2021.05.11.443443 — Posted: 2021-05-14
Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species
Schafer, A., Gralinski, L. E., Leist, S. R., Winkler, E. S., Hampton, B. K., Mooney, M. A., Jensen, K. L., Graham, R. L., Agnihothram, S., Jeng, S., Chamberlin, S., Bell, T. A., Scobey, D. T., VanBlargan, L. A., Thackray, L. B., Hock, P., Miller, D. R., Shaw, G. D., Pardo Manuel de Villena, F., McWeeney, S. K., Montgomery, S. A., Diamond, M. S., Heise, M. T., Menachery, V. D., Ferris, M. T., Baric, R. S.
10.1101/2021.05.14.444205 — Posted: 2021-05-14
Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses
Perez-Zsolt, D., Munoz Basagoiti, J., Rodo, J., Elousa, M., Raich Regue, D., Risco, C., Sachse, M., Pino, M., Gumber, S., Paiardini, M., Chojnacki, J., Erkizia, I., Muniz, X., Ballana, E., Riveira Munoz, E., Noguera-Julian, M., Paredes, R., Trinite, B., Tarres Freixas, F., Blanco, I., Guallar, V., Carrillo, J., Blanco, J., Telenti, A., Heyn, H., Segales, J., Clotet, B., Martinez-Picado, J., Vergara-Alert, J., Izquierdo-Useros, N.
10.1101/2021.05.11.443572 — Posted: 2021-05-14
Family responsibilities and mental health of kindergarten educators during the first COVID-19 pandemic lockdown in Ontario, Canada
Spadafora, N., Reid-Westoby, C., Pottruff, M., Janus, M.
10.1101/2021.05.11.21257057 — Posted: 2021-05-14
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada
Piche-Renaud, P.-P., Ji, C., Farrar, D. S., Friedman, J. N., Science, M., Kitai, I., Burey, S., Feldman, M., Morris, S. K.
10.1101/2021.05.11.21257048 — Posted: 2021-05-14
Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modeling study
Tan, J., Ge, Y., Martinez, L., Chen, Z., Li, C., Westbrook, A., Chen, E., Pan, J., Li, Y., Ling, F., Sun, J., Huang, H., Shen, Y.
10.1101/2021.05.11.21257060 — Posted: 2021-05-14
First comparison of conventional activated sludge versus root-zone treatment for SARS-CoV-2 RNA removal from wastewaters: statistical and temporal significance
Kumar, M., Joshi, M., Kuroda, K., Bhattacharya, P., Barcello, D.
10.1101/2021.05.09.21256898 — Posted: 2021-05-14
SARS-CoV-2 lineage dynamics in England from January to March 2021 inferred from representative community samples
Eales, O., Page, A., Tang, S. N., Walters, C. E., Wang, H., Haw, D., Trotter, A. J., Le Viet, T., Foster-Nyarko, E., Prosolek, S., Atchinson, C., Ashby, D., Cooke, G., Barclay, W., Donnelly, C. A., O'Grady, J., Volz, E., The COVID-19 Genomics UK (COG-UK) Consortium, , Darzi, A., Ward, H., Elliott, P., Riley, S.
10.1101/2021.05.08.21256867 — Posted: 2021-05-14
Systematic Testing for SARS-CoV-2 Infection Among Essential Workers in Montreal, Canada: A Prospective Observational and Cost Assessment Study
Campbell, J. R., Dion, C., Uppal, A., Yansouni, C. P., Menzies, D.
10.1101/2021.05.12.21256956 — Posted: 2021-05-14
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
Sivapalasingam, S., Lederer, D., Bhore, R., Hajizadeh, N., Criner, G., Hossain, R., Mahmood, A., Giannelou, A., Somersan-Karakaya, S., O'Brien, M., Boyapati, A., Parrino, J., Musser, B., Labriola-Tompkins, E., Ramesh, D., Purcell, L., Gulabani, D., Kampman, W., Waldron, A., Ng Gong, M., Saggar, S., Sperber, S., Menon, V., Stein, D., Sobieszczyk, M., Park, W., Aberg, J., Brown, S., Kosmicki, J., Horowitz, J., Ferreira, M., Baras, A., Kowal, B., DiCioccio, A. T., Akinlade, B., Nivens, M., Braunstein, N., Herman, G., Yancopoulos, G., Weinreich, D., Sarilumab-COVID-19 Study Team
10.1101/2021.05.13.21256973 — Posted: 2021-05-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).